Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Silence Therapeutics (SLN)
Share Price: 111.50p Change Today: 2.50p  Market Cap: 77.83m

SLN Overview

Silence Therapeutics is in the pharma and biotech sector and is currently trading at 111.50p per share. In the last year Silence Therapeutics's share price has ranged from 100.00p to 171.00p and brokers are currently rating this stock as 'neutral'.

1 Day Chart

6 Month Chart

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-11 0.69 (5.74) (56.17)p n/a n/a n/a n/a 0.0%
31-Dec-12 0.16 (26.28) (6,750.00)p n/a n/a n/a n/a 0.0%
31-Dec-13 0.12 (9.00) (20.00)p n/a n/a n/a n/a 0.0%
31-Dec-14 0.01 (11.98) (22.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.43) (10.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 n/a (12.60) (16.16)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (13.70) (17.01)p n/a n/a n/a n/a 0.0%

Copyright © 2016 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

CRISPR/Cas9 Gene Editing Data 15-Nov-2016 07:00 RNS
Half-year Report 27-Sep-2016 07:00 RNS
Notice of Results 22-Sep-2016 07:00 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 111.50p
Change Today 2.50p
% Change 2.29 %
Volume 0
02-Dec-16 Close 111.50p
Shares Issued 69.80m
Market Cap 77.83m
Year End 31-Dec-15

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 2
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for --2016

Time Volume / Share Price
0 @ 0.000p

SLN Key Personnel

CEO Ali Mortazavi


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com